BIOMAT Database Logo BIOMAT Database Logo

Interrelationships between body weight, insulin secretion from B cell and metabolic control in type 2 (non-insulin-dependent) diabetics with fasting hyperglycemia. 1987

R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias

Related Publications

R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
B-cell secretion in non-diabetics and insulin-dependent diabetics.
January 1981, Acta medica Scandinavica. Supplementum,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics.
May 2002, Obesity research,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
Benfluorex action on metabolic control and insulin sensitivity in type 2 non-insulin dependent diabetics.
January 1989, Panminerva medica,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
Vasopressin secretion during hyperglycemia in insulin-dependent diabetics.
January 1988, Diabete & metabolisme,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
Effect of correction of hyperglycemia on left ventricular function in non-insulin-dependent (type 2) diabetics.
January 1983, Acta medica Scandinavica,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
October 1969, The Journal of clinical investigation,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
[Diabetic neuropathy: thermal sensation and metabolic control in non-insulin-dependent diabetics].
November 1997, Revista medica de Chile,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
September 1983, Diabete & metabolisme,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control.
October 1990, East African medical journal,
R Pasquali, and P Buratti, and P Biso, and L Mattioli, and M Capelli, and N Melchionda, and G Labò
[Correlations between insulin sensitivity with anthropometric and metabolic parameters in type 2 diabetics].
June 2018, Annales de cardiologie et d'angeiologie,
Copied contents to your clipboard!